InvestWiser

AcouSort AB

ACOUNasdaq StockholmHealthcareMarket value 58 m SEK
2.73SEK −1.4%
last day · Price as of 18 November 2026

The answer first

Does AcouSort beat the market?

No, AcouSort has not beaten the market over the last year.

AcouSort+3.0%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 12% of Nordic stocks

    • Quality43
    • Value4
    • Trend41

    No. 156 of 195 in healthcare

Max for seven days

Follow AcouSort with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on AcouSort

From today, at a price of 2.73 SEK. Write why you follow AcouSort, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about AcouSort

Your first answer is free, no account needed.

Do you own AcouSort, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with AcouSort and a few more. Free, no card.

Past year against the exchange and Super Stock
AcouSort+3.0%Stockholm (OMXSGI)+17.6%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • AcouSort has risen 3.0% over the past year, including dividends.
  • Overall, AcouSort ranks better than 12% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 92.3%. The price is 91.4% below its peak now.

What do analysts think of AcouSort?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

12

Quality, value and trend together. Better than 12% of Nordic stocks.

No. 156 of 195 in healthcare

Quality43
The company · Fundamentals: the accounts

Medium An average company: the accounts are neither especially strong nor weak.

No. 142 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity–
  • Asset turnoverSales divided by everything the company owns0.37
  • Return on equityProfit divided by equity−114.5%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value4
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 171 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity5.6
  • P/SPrice divided by sales6.9
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend41
The share price · Technical: the price trend

Medium The share price has moved about like most stocks over the last year.

No. 82 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−10.8%
  • 6 months−40.7%
  • 9 months−2.5%
  • 12 months+3.0%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−23.7%
3 years, per year
−44.0%
5 years, per year
−36.5%
Year to date
−3.5%
Largest fall, 3 years
−92.3%
From a peak to the bottom
From the peak now
−91.4%
How far the price is from the peak
Volatility, 1 year
99.3%
How much the price swings over a year
Beta, 1 year
0.33
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own AcouSort

One fund we follow owns AcouSort. The share is how much of the fund the stock makes up.

  • Sweden1

From the funds' latest known holdings.

About AcouSort

AcouSort AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 11 employees.

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle s…

See the full analysis of AcouSort.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market